ABVC BioPharma, Inc.
ABVC
$2.73
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.06M | -1.74M | -3.73M | -4.35M | -7.48M |
| Total Depreciation and Amortization | 381.00K | 414.50K | 403.10K | 583.20K | 583.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.51M | 306.70K | 2.21M | 2.97M | 4.58M |
| Change in Net Operating Assets | -593.20K | -52.90K | -372.20K | -628.90K | -639.70K |
| Cash from Operations | -1.76M | -1.07M | -1.49M | -1.43M | -2.96M |
| Capital Expenditure | -- | -- | -- | 0.00 | -21.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -665.80K | -501.60K | -501.60K | -347.40K | -400.00K |
| Cash from Investing | -665.80K | -501.60K | -501.60K | -347.40K | -421.20K |
| Total Debt Issued | 698.60K | 1.58M | 1.89M | 1.31M | -511.20K |
| Total Debt Repaid | -459.50K | -385.40K | -356.10K | -365.60K | -186.50K |
| Issuance of Common Stock | 2.56M | 652.70K | 241.00K | 164.70K | 1.18M |
| Repurchase of Common Stock | -7.30K | -7.30K | -7.30K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -171.70K | 394.10K | 508.90K | 2.94M |
| Cash from Financing | 2.79M | 1.67M | 2.16M | 1.62M | 3.42M |
| Foreign Exchange rate Adjustments | -36.90K | 8.30K | -24.60K | -197.00K | -42.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 333.60K | 100.60K | 147.00K | -351.10K | 500.00 |